Search

+44 (0)20 7722 1221

info@thembsgroup.co.uk

VIEW OPPORTUNITIES

Healthcare

As the Healthcare sector emerges from a time of immense pressure and high visibility, we see huge investment, potential and opportunity ahead

Truly dynamic and innovative at its core, Healthcare is poised for a period of growth and transformation. Driven by a range of factors – including Covid-19; greater emphasis on personalisation; digitisation and technological innovation; changing demographics; and shifting customer and patient expectations – organisations of all sizes and ownership structures seek the right leaders to seize this opportunity.

Supporting clients at Board, Executive Committee and leadership levels, we combine extensive experience in and a deep understanding of the wide and varied Healthcare sector, including its clinical leadership, as well as access to relevant talent pools in adjacent consumer-facing industries.

View current opportunities

The MBS Group acts as an advisor to NHS and other public sector bodies on senior appointments. To view current appointments, click here.

Our Experience

Clinical Services

Life Sciences
HealthTech & Digital Healthcare
Insurers
Healthcare Systems
Medical Devices & Diagnostics

Selected Clients

Latest MBS News & Intelligence

Moonpig tumbles after hefty share sale by private equity backers. Moonpig experienced its worst day of trading in three years as private equity backers cashed in significant stakes at a double-digit discount.
Baron Capital boosts valuation of India’s Swiggy. Baron Capital has increased the value of its stake in the food delivery firm, boosting the startup’s valuation to $12.16bn, surpassing its initial post-money valuation of $10.7bn. Swiggy holds roughly 45% market share in the Indian food delivery space.
Kering and EssilorLuxottica among possible buyers for Italy’s Marcolin. According to reports, Kering and EssilorLuxottica are among the possible suiters for Italian eyewear manufacturer Marcolin. Marcolin’s owner, private equity firm PAI Partners, is seeking a valuation of about €1.3bn.